The STEPUPIORS team participated at the annual conference organized by European Association for Cancer Research (EACR) “Innovative Cancer Science” held in Lisbon, Portugal, on June 16-19, 2025. The congress was attended by more than 2,800 participants from 85 countries.
At the EACR2025 congress Ana Vuletić presented project abstract “Novel 1-benzhydryl piperazine scaffoldbased HDAC inhibitor b7 induces synergistic antiproliferative effect with vemurafenib in colorectal cancer cells harboring BRAF mutation“ at Cancer Cell Biology poster session. Snežana Bjelogrlić presented the study „SWOT Analysis for Maintaining the Sustainability of Newly Established Rectal Cancer Biobank at the Institute for Oncology and Radiology of Serbia“ during the poster session Prevention and Early Detection.
